Leslie Trigg Sells 10,227 Shares of Outset Medical, Inc. (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 10,227 shares of the stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $1.29, for a total transaction of $13,192.83. Following the completion of the transaction, the chief executive officer now directly owns 894,624 shares of the company’s stock, valued at approximately $1,154,064.96. This trade represents a 1.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Leslie Trigg also recently made the following trade(s):

• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total value of $4,516.00.

Outset Medical Stock Down 10.9 %

OM stock opened at $0.98 on Friday. The company has a debt-to-equity ratio of 4.12, a current ratio of 6.49 and a quick ratio of 5.04. The company’s 50 day simple moving average is $1.00 and its 200-day simple moving average is $1.50. Outset Medical, Inc. has a 12 month low of $0.44 and a 12 month high of $5.27. The firm has a market capitalization of $51.49 million, a PE ratio of -0.36 and a beta of 2.05.

Institutional Investors Weigh In On Outset Medical

A number of large investors have recently bought and sold shares of the stock. GSA Capital Partners LLP raised its position in shares of Outset Medical by 924.7% in the third quarter. GSA Capital Partners LLP now owns 1,111,612 shares of the company’s stock valued at $753,000 after buying an additional 1,003,135 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Outset Medical by 118.5% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,538,859 shares of the company’s stock valued at $5,925,000 after acquiring an additional 834,663 shares during the last quarter. Millennium Management LLC lifted its stake in shares of Outset Medical by 58.8% during the 2nd quarter. Millennium Management LLC now owns 1,942,899 shares of the company’s stock worth $7,480,000 after purchasing an additional 719,412 shares during the period. Marshall Wace LLP boosted its holdings in shares of Outset Medical by 487.8% during the second quarter. Marshall Wace LLP now owns 314,187 shares of the company’s stock worth $1,210,000 after purchasing an additional 260,740 shares during the last quarter. Finally, Point72 Asset Management L.P. purchased a new stake in shares of Outset Medical in the second quarter valued at $827,000.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 target price on shares of Outset Medical in a research report on Tuesday.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.